pulmonary hypertension associated with chronic lung diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 18-85 years old; 2. WHO Group 3 PH;chronic lung diseases according to the internationally recognized standards and standard diagnostic processt: 3. Chronic obstructive pulmonary disease, interstitial lung disease, bronchiectasis, respiratory sleep disease, alveolar hypoventilation disease, thoracic deformity; 4. Stable patients: no acute aggravation within 1 month; 5.Iinformed consent has been signed for this study.
Exclusion criteria
Exclusion criteria: With severe pulmonary infection within recent 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality or lung transplantation within 3 years;Acute exacerbation of heart failure or chronic lung disease with 3 years; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of pulmonary hypertension associated with chronic lung diseases;Prevalence of severe pulmonary hypertension associated with chronic lung diseases; | — |
Countries
China
Contacts
Shanghai Pulmonary Hospital